• Topics

  • Formats

Topic: MA Code Edition 20 reactive vs Proactive Scientific Exchange – Stakeholder Perspectives

 

ARCS Australia, in collaboration with the Medical Affairs Professionals of Australasia (MAPA), invites you to an interactive panel webinar exploring the implications of Edition 20 of the Medicines Australia Code of Conduct. The session will focus on the shift from reactive to proactive scientific exchange and how this change impacts key stakeholders across the sector.

The discussion will feature a diverse panel including representatives from pharmaceutical companies (across medical, ethics and compliance, and commercial roles), a healthcare professional, and Sophie Seck from Medicines Australia. The panel will provide real-world insights into how the new Code is shaping practice, decision-making, and engagement across the industry.

Participants will have the opportunity to engage in live polling and a Q&A session, ensuring an interactive and thought-provoking experience. This webinar is ideal for professionals working in medical affairs, regulatory affairs, ethics and compliance, and commercial strategy who want to stay informed and ahead of the curve.

Highlights:

  • Overview of key changes in Edition 20 of the Medicines Australia Code of Conduct
  • Perspectives from pharmaceutical companies, healthcare professionals, and Medicines Australia
  • Real-world examples of the Code’s application and implications
  • Live polling to capture audience perspectives
  • Interactive Q&A session and announcement of upcoming initiatives

Register now to join the conversation and gain valuable insights into the evolving compliance landscape.

Available Dates

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?